Age: 69.0
Sex: M
Vaccine: VARZOS
Symptoms: Sleep disorder
Clinical narrative: Other related health complications; Shingles; could not sleep; This spontaneous report was received from a 69 year old male patient with cholesterol abnormal, diabetes and no known drug reactions or allergies refers to himself. The patient's medical history included chicken pox as a boy. Concomitant medication included unspecified cholesterol and diabetes medication. In approximately July 2013 (reported as 2 to 3 months ago), the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) to prevent shingles (dose, dose number, route, anatomical site of vaccination, lot # and expiration date were not provide). On approximately 03-OCT-2013 (reported as about a week ago), the patient had shingles. It started with soreness on the right side of his abdomen, then a rash that spread to the navel area. He had sharp pain internally and externally and could not sleep for 4 days. Currently the pain was gone but he still had some rash and soreness. The patient sought medical attention by doctor visit. As treatment he received calamine lotion and unspecified psychotropic. Blood work was performed but the result was unknown. At the time of the report, the outcome of events was reported as recovering. The causal assessment between the events and zoster vaccine live (ZOSTAVAX) was not reported.  Follow up information was received on 02-MAR-2021 from a lawyer regarding a case in litigation and refers to 69-year-old male patient. No information was provided regarding concomitant medications, concurrent conditions or medical history. On 10-JUN-2013, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (also reported as shingles vaccine) prophylaxis (dose, dose number, route, anatomical site of vaccination, lot # and expiration date were not provided) at a pharmacy (he was 69-year-old when he received the vaccine). On 02-OCT-2013, as a result of his receipt of zoster vaccine live (ZOSTAVAX), he suffered shingles, including any and all of its sequelae. On an unknown date, he also experienced other related health conditions (ill-defined disorder). As a result of his receipt of zoster vaccine live (ZOSTAVAX), the patient had been caused to suffer severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages and loss of consortium damages. As a result of the foregoing acts and omissions, the patient was caused to suffer serious and dangerous side effects including shingles, as well as other severe and personal injuries which were permanent and lasting in nature, physical pain and mental anguish, including diminished enjoyment of life, as well as the need for lifelong medical treatment, monitoring and/or medications. As a result of the foregoing acts and omissions the patient also required and/or would require more health care and services and did incur medical, health, incidental and related expenses. In addition, the patient required and would continue to require healthcare and services. He had incurred and would continue to incur medical and related expenses. Besides, he had suffered and would continue to suffer diminished capacity for the enjoyment of life, a diminished quality of life, increased risk of premature death, aggravation of preexisting conditions, activation of latent conditions, and other losses and damages. The patient reported direct medical losses and costs included physician care, monitoring, and treatment. He had incurred and would continue to incur mental and physical pain and suffering. The outcome of herpes zoster and ill-defined disorder was reported as not recovered. The causal relationship between the events and zoster vaccine live (ZOSTAVAX) was assessed as related.  Herpes zoster and ill-defined disorder were considered disabling events by the reporter.